| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Merck: FDA reviewing tablet to eliminate allergy

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

By The Associated Press
Thursday, March 28, 2013, 12:01 a.m.

Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that reduces symptoms over time, rather than just temporarily relieving the sneezing and itching.

The treatment, a tablet that dissolves under the tongue, could become the first alternative available in the United States to a long series of uncomfortable allergy shots. Both methods work by gradually desensitizing the patient's immune system to the substance triggering the allergic reaction. Merck's immunotherapy, still unnamed, would be taken daily throughout allergy season.

for three years.

The company, which is based in Whitehouse Station, N.J., also recently applied to the Food and Drug Administration for approval to sell an immunotherapy tablet for ragweed pollen.

Subscribe today! Click here for our subscription offers.



Show commenting policy

Most-Read Business Headlines

  1. Alcoa supplying parts for military jets under $1.1B pact with Lockheed Martin
  2. Rice, Gulfport team on Utica shale pipeline system
  3. Renewed Anheuser-Busch InBev bid for SABMiller ups stake in beer battle
  4. Bear sharpens claws on ‘old Pittsburgh’
  5. Consumers bureau targets mandatory arbitration
  6. Energy efficiency goes mainstream with help of regulations, demand
  7. Google is latest tech giant to claim space in mobile news
  8. Power plants challenged by carbon capture and storage
  9. Eat’n Park sells Cura division that serves hospitals and senior living
  10. Credit bureau Experian keeps info on cellular firm’s customers
  11. AB InBev ups its offer for SABMiller to create beer giant